
Noble E. Jarrell
Examiner (ID: 13867, Phone: (571)272-9077 , Office: P/1625 )
| Most Active Art Unit | 1699 |
| Art Unit(s) | 1624, 1622, 1625, 1699, 1609, 1629 |
| Total Applications | 1459 |
| Issued Applications | 965 |
| Pending Applications | 172 |
| Abandoned Applications | 340 |
Applications
| Application number | Title of the application | Filing Date | Status |
|---|---|---|---|
Array
(
[id] => 10791451
[patent_doc_number] => 20160137606
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2016-05-19
[patent_title] => 'NOVEL PYRIDINE DERIVATIVES'
[patent_app_type] => utility
[patent_app_number] => 15/002681
[patent_app_country] => US
[patent_app_date] => 2016-01-21
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 84631
[patent_no_of_claims] => 22
[patent_no_of_ind_claims] => 6
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 15002681
[rel_patent_id] =>[rel_patent_doc_number] =>) 15/002681 | NOVEL PYRIDINE DERIVATIVES | Jan 20, 2016 | Abandoned |
Array
(
[id] => 11009787
[patent_doc_number] => 20160206740
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2016-07-21
[patent_title] => 'CONJUGATED LIPOMERS AND USES THEREOF'
[patent_app_type] => utility
[patent_app_number] => 14/995842
[patent_app_country] => US
[patent_app_date] => 2016-01-14
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 35
[patent_figures_cnt] => 35
[patent_no_of_words] => 39788
[patent_no_of_claims] => 20
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 14995842
[rel_patent_id] =>[rel_patent_doc_number] =>) 14/995842 | Conjugated lipomers and uses thereof | Jan 13, 2016 | Issued |
Array
(
[id] => 10761868
[patent_doc_number] => 20160108020
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2016-04-21
[patent_title] => 'QUINAZOLINEDIONE DERIVATIVES AS PARP INHIBITORS'
[patent_app_type] => utility
[patent_app_number] => 14/985028
[patent_app_country] => US
[patent_app_date] => 2015-12-30
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 9408
[patent_no_of_claims] => 20
[patent_no_of_ind_claims] => 9
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 14985028
[rel_patent_id] =>[rel_patent_doc_number] =>) 14/985028 | QUINAZOLINEDIONE DERIVATIVES AS PARP INHIBITORS | Dec 29, 2015 | Abandoned |
Array
(
[id] => 14491905
[patent_doc_number] => 10332751
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2019-06-25
[patent_title] => Monomer, organic layer composition, organic layer, and method of forming patterns
[patent_app_type] => utility
[patent_app_number] => 14/979634
[patent_app_country] => US
[patent_app_date] => 2015-12-28
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 6330
[patent_no_of_claims] => 15
[patent_no_of_ind_claims] => 3
[patent_words_short_claim] => 26
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 14979634
[rel_patent_id] =>[rel_patent_doc_number] =>) 14/979634 | Monomer, organic layer composition, organic layer, and method of forming patterns | Dec 27, 2015 | Issued |
Array
(
[id] => 12079450
[patent_doc_number] => 20170342038
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2017-11-30
[patent_title] => 'A METHOD FOR PREPARING GADOBUTROL'
[patent_app_type] => utility
[patent_app_number] => 15/528281
[patent_app_country] => US
[patent_app_date] => 2015-12-28
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 2518
[patent_no_of_claims] => 14
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 15528281
[rel_patent_id] =>[rel_patent_doc_number] =>) 15/528281 | Method for preparing gadobutrol | Dec 27, 2015 | Issued |
Array
(
[id] => 10822014
[patent_doc_number] => 20160168178
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2016-06-16
[patent_title] => 'MULTIMERIC DUAL-MODALITY BREAST CANCER DIAGNOSTIC AGENTS'
[patent_app_type] => utility
[patent_app_number] => 14/975854
[patent_app_country] => US
[patent_app_date] => 2015-12-21
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 7
[patent_figures_cnt] => 7
[patent_no_of_words] => 5365
[patent_no_of_claims] => 20
[patent_no_of_ind_claims] => 3
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 14975854
[rel_patent_id] =>[rel_patent_doc_number] =>) 14/975854 | Multimeric dual-modality breast cancer diagnostic agents | Dec 20, 2015 | Issued |
Array
(
[id] => 13636717
[patent_doc_number] => 09845315
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2017-12-19
[patent_title] => Method for preparing Afatinib and intermediate thereof
[patent_app_type] => utility
[patent_app_number] => 14/957607
[patent_app_country] => US
[patent_app_date] => 2015-12-03
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 3136
[patent_no_of_claims] => 8
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 53
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 14957607
[rel_patent_id] =>[rel_patent_doc_number] =>) 14/957607 | Method for preparing Afatinib and intermediate thereof | Dec 2, 2015 | Issued |
Array
(
[id] => 13209079
[patent_doc_number] => 10118896
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2018-11-06
[patent_title] => Antagonists of the kappa opioid receptor
[patent_app_type] => utility
[patent_app_number] => 15/529290
[patent_app_country] => US
[patent_app_date] => 2015-11-25
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 3
[patent_figures_cnt] => 6
[patent_no_of_words] => 18644
[patent_no_of_claims] => 18
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 177
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 15529290
[rel_patent_id] =>[rel_patent_doc_number] =>) 15/529290 | Antagonists of the kappa opioid receptor | Nov 24, 2015 | Issued |
Array
(
[id] => 14301355
[patent_doc_number] => 10290812
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2019-05-14
[patent_title] => Compound for organic photoelectric device and organic photoelectric device image sensor, and electronic device including the same
[patent_app_type] => utility
[patent_app_number] => 14/951718
[patent_app_country] => US
[patent_app_date] => 2015-11-25
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 22
[patent_figures_cnt] => 22
[patent_no_of_words] => 13417
[patent_no_of_claims] => 22
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 184
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 14951718
[rel_patent_id] =>[rel_patent_doc_number] =>) 14/951718 | Compound for organic photoelectric device and organic photoelectric device image sensor, and electronic device including the same | Nov 24, 2015 | Issued |
Array
(
[id] => 15227525
[patent_doc_number] => 10501472
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2019-12-10
[patent_title] => Method to isolate inoscavin a from
[patent_app_type] => utility
[patent_app_number] => 15/775007
[patent_app_country] => US
[patent_app_date] => 2015-11-23
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 1
[patent_figures_cnt] => 5
[patent_no_of_words] => 5877
[patent_no_of_claims] => 5
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 63
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 15775007
[rel_patent_id] =>[rel_patent_doc_number] =>) 15/775007 | Method to isolate inoscavin a from | Nov 22, 2015 | Issued |
Array
(
[id] => 11908203
[patent_doc_number] => 09777007
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2017-10-03
[patent_title] => 'Short-acting benzodiazepine salts and their polymorphic forms'
[patent_app_type] => utility
[patent_app_number] => 14/948889
[patent_app_country] => US
[patent_app_date] => 2015-11-23
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 64
[patent_figures_cnt] => 68
[patent_no_of_words] => 20065
[patent_no_of_claims] => 3
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 14
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 14948889
[rel_patent_id] =>[rel_patent_doc_number] =>) 14/948889 | Short-acting benzodiazepine salts and their polymorphic forms | Nov 22, 2015 | Issued |
Array
(
[id] => 10795365
[patent_doc_number] => 20160141523
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2016-05-19
[patent_title] => 'LUMINESCENT COMPLEXES AND DISPLAY DEVICES'
[patent_app_type] => utility
[patent_app_number] => 14/944427
[patent_app_country] => US
[patent_app_date] => 2015-11-18
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 3
[patent_figures_cnt] => 3
[patent_no_of_words] => 10213
[patent_no_of_claims] => 26
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 14944427
[rel_patent_id] =>[rel_patent_doc_number] =>) 14/944427 | Luminescent complexes and display devices | Nov 17, 2015 | Issued |
Array
(
[id] => 13478947
[patent_doc_number] => 20180291016
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2018-10-11
[patent_title] => ANTI-HCMV COMPOSITIONS AND METHODS
[patent_app_type] => utility
[patent_app_number] => 15/525504
[patent_app_country] => US
[patent_app_date] => 2015-11-09
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 17106
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -22
[patent_words_short_claim] => 2
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 15525504
[rel_patent_id] =>[rel_patent_doc_number] =>) 15/525504 | Anti-HCMV compositions and methods | Nov 8, 2015 | Issued |
| 14/935454 | METHOD FOR PREPARING AFATINIB AND INTERMEDIATE THEREOF | Nov 8, 2015 | Abandoned |
Array
(
[id] => 10790134
[patent_doc_number] => 20160136290
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2016-05-19
[patent_title] => 'Phospholipid Ether Analogs as Cancer-Targeting Drug Vehicles'
[patent_app_type] => utility
[patent_app_number] => 14/934203
[patent_app_country] => US
[patent_app_date] => 2015-11-06
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 15
[patent_figures_cnt] => 15
[patent_no_of_words] => 15791
[patent_no_of_claims] => 12
[patent_no_of_ind_claims] => 3
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 14934203
[rel_patent_id] =>[rel_patent_doc_number] =>) 14/934203 | Phospholipid ether analogs as cancer-targeting drug vehicles | Nov 5, 2015 | Issued |
Array
(
[id] => 13461477
[patent_doc_number] => 20180282281
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2018-10-04
[patent_title] => IMMUNOREGULATORY AGENTS
[patent_app_type] => utility
[patent_app_number] => 15/524396
[patent_app_country] => US
[patent_app_date] => 2015-11-05
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 58714
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -15
[patent_words_short_claim] => 2
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 15524396
[rel_patent_id] =>[rel_patent_doc_number] =>) 15/524396 | IMMUNOREGULATORY AGENTS | Nov 4, 2015 | Abandoned |
Array
(
[id] => 15225007
[patent_doc_number] => 10500207
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2019-12-10
[patent_title] => Compounds for the treatment of diseases associated with amyloid or amyloid-like proteins
[patent_app_type] => utility
[patent_app_number] => 14/930442
[patent_app_country] => US
[patent_app_date] => 2015-11-02
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 16
[patent_figures_cnt] => 16
[patent_no_of_words] => 75567
[patent_no_of_claims] => 18
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 168
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 14930442
[rel_patent_id] =>[rel_patent_doc_number] =>) 14/930442 | Compounds for the treatment of diseases associated with amyloid or amyloid-like proteins | Nov 1, 2015 | Issued |
Array
(
[id] => 14558741
[patent_doc_number] => 10347844
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2019-07-09
[patent_title] => Material for organic electroluminescent device and organic electroluminescent device using the same
[patent_app_type] => utility
[patent_app_number] => 14/925960
[patent_app_country] => US
[patent_app_date] => 2015-10-28
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 2
[patent_figures_cnt] => 2
[patent_no_of_words] => 6034
[patent_no_of_claims] => 11
[patent_no_of_ind_claims] => 3
[patent_words_short_claim] => 204
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 14925960
[rel_patent_id] =>[rel_patent_doc_number] =>) 14/925960 | Material for organic electroluminescent device and organic electroluminescent device using the same | Oct 27, 2015 | Issued |
Array
(
[id] => 11443274
[patent_doc_number] => 20170044295
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2017-02-16
[patent_title] => 'POLYMERS, SUBSTRATES, METHODS FOR MAKING SUCH, AND DEVICES COMPRISING THE SAME'
[patent_app_type] => utility
[patent_app_number] => 14/885557
[patent_app_country] => US
[patent_app_date] => 2015-10-16
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 10
[patent_figures_cnt] => 10
[patent_no_of_words] => 7440
[patent_no_of_claims] => 9
[patent_no_of_ind_claims] => 3
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 14885557
[rel_patent_id] =>[rel_patent_doc_number] =>) 14/885557 | POLYMERS, SUBSTRATES, METHODS FOR MAKING SUCH, AND DEVICES COMPRISING THE SAME | Oct 15, 2015 | Abandoned |
Array
(
[id] => 12755074
[patent_doc_number] => 20180143525
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2018-05-24
[patent_title] => PHOTOCHROMIC METAL ORGANIC FRAMEWORKS FOR INKLESS AND ERASABLE PRINTING
[patent_app_type] => utility
[patent_app_number] => 15/527960
[patent_app_country] => US
[patent_app_date] => 2015-09-30
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 6153
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -11
[patent_words_short_claim] => 2
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 15527960
[rel_patent_id] =>[rel_patent_doc_number] =>) 15/527960 | Photochromic metal organic frameworks for inkless and erasable printing | Sep 29, 2015 | Issued |